Danaher Announces Quarterly Dividend
Rhea-AI Summary
Danaher (NYSE: DHR) announced a regular quarterly cash dividend of $0.32 per share. The dividend is payable on January 30, 2026 to holders of record on December 26, 2025.
Positive
- $0.32 per share regular quarterly cash dividend declared
- Dividend payable Jan 30, 2026 to record holders on Dec 26, 2025
Negative
- Dividend creates a company cash outflow payable on Jan 30, 2026
News Market Reaction
On the day this news was published, DHR gained 3.22%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mild, mixed moves: TMO +0.4%, IDXX +0.94%, LH +0.86%, MTD +0.57%, A -0.46%, while DHR is up 3.22%, suggesting a more company-specific setup.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 11 | Conference presentation | Positive | +1.7% | CEO presentation at Jefferies Global Healthcare Conference with webcast access. |
| Oct 21 | Earnings results | Positive | +5.9% | Q3 2025 results with revenue and EPS growth and maintained guidance. |
| Sep 23 | Earnings call setup | Neutral | -2.0% | Scheduling details for upcoming Q3 2025 earnings conference call. |
| Sep 10 | Product launch | Positive | -0.9% | Launch of BD‑Tau RUO immunoassay and development of Aβ‑42 test. |
| Sep 09 | Dividend declaration | Positive | -0.9% | Board approval of regular quarterly cash dividend of $0.32 per share. |
News reactions have been mixed, with earnings and conference updates seeing positive alignment while product and dividend headlines more often saw muted or negative follow-through.
Over the last few months, Danaher reported Q3 2025 results with 4.5% YoY revenue growth to $6.1B and adjusted diluted EPS of $1.89, which coincided with a 5.94% gain. Conference participation and product launches, including a BD‑Tau immunoassay test, had smaller or negative moves. Prior dividend announcements at $0.32 per share saw modest price changes between -0.9% and +1.6%, so today’s regular dividend continues a pattern of steady shareholder returns.
Market Pulse Summary
This announcement details a regular quarterly cash dividend of $0.32 per share, payable on January 30, 2026 to holders of record on December 26, 2025. It continues Danaher’s 2025 pattern of consistent payouts following an earlier 18.5% dividend increase. In context of recent Q3 2025 results, with revenue of $6.1B and adjusted EPS of $1.89, investors may watch future dividends, earnings trends, and ongoing insider activity for signals on capital allocation and confidence.
AI-generated analysis. Not financial advice.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-announces-quarterly-dividend-302637034.html
SOURCE Danaher Corporation
FAQ
What dividend did Danaher (DHR) announce on December 9, 2025?
When is Danaher's (DHR) dividend payable and what's the record date?
Who is eligible to receive Danaher's (DHR) January 30, 2026 dividend?
How much cash will individual Danaher (DHR) shareholders receive per share for the declared dividend?
